logo

For the Inventor, By the Inventor

Hegenheim, France

Patrice Guitard

This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignee: Novartis Ag. Active years: 1999-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patrice Guitard. Retrieved from https://idiyas.com/inventor/patrice-guitard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 110(Granted Patents)


Location History:

  • Hégenheim, FR (2001)
  • Hegenheim, FR (1999 - 2005)

Company Filing History:

goldMedal4 out of 3,977 
 
Novartis Ag
 patents

Years Active: 1999-2005

Loading Chart...
4 patents (USPTO):Explore Patents
1. 6956043 - Pharmaceutical compositions comprising 33-epi-chloro-33-desoxy-ascomycin solid dispersions (2005-10-18),
2. 6599535 - Pharmaceutical compositions (2003-07-29),
3. 6197781 - Pharmaceutical compositions (2001-03-06),
4. 6004973 - Pharmaceutical compositions comprising rafamycin coprecipitates (1999-12-21),

Title: The Innovative Contributions of Patrice Guitard

Introduction

Patrice Guitard is a notable inventor based in Hegenheim, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work primarily focuses on pharmaceutical compositions that utilize advanced solid dispersion techniques.

Latest Patents

Among his latest patents, Guitard has developed pharmaceutical compositions comprising 33-epi-chloro-33-desoxy-ascomycin solid dispersions. This innovative composition includes a macrolide, such as a rapamycin or an ascomycin, combined with a carrier medium. His work in this area aims to enhance the efficacy and delivery of pharmaceutical agents.

Career Highlights

Patrice Guitard is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to further his research and development efforts in the pharmaceutical sector. His contributions have been instrumental in advancing the understanding and application of solid dispersion technologies in drug formulation.

Collaborations

Throughout his career, Guitard has collaborated with several esteemed colleagues, including Barbara Haeberlin and Rainer Link. These collaborations have fostered a productive environment for innovation and have led to the successful development of various pharmaceutical products.

Conclusion

Patrice Guitard's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a commitment to improving drug formulations and patient outcomes. His contributions continue to influence the field and inspire future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…